GH Research (GHRS) EBT Growth (1y) (2021 - 2025)
GH Research (GHRS) EBT Growth (1y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
GH Research |
9.73 Bn |
9.63 Bn |
- |
-60.61% |
| Date | Value |
|---|
| Dec 31, 2025 |
-60.61% |
| Sep 30, 2025 |
-15.73% |
| Jun 30, 2025 |
10.50% |
| Mar 31, 2025 |
-41.04% |
| Dec 31, 2024 |
21.91% |
| Sep 30, 2024 |
-114.45% |
| Jun 30, 2024 |
-34.29% |
| Mar 31, 2024 |
29.91% |
| Dec 31, 2023 |
32.04% |
| Sep 30, 2023 |
-1,180.95% |
| Jun 30, 2023 |
-2,414.07% |
| Mar 31, 2023 |
-89.78% |
| Dec 31, 2022 |
-305.43% |
| Sep 30, 2022 |
75.99% |
| Jun 30, 2022 |
115.72% |
| Mar 31, 2022 |
-401.57% |
| Dec 31, 2021 |
-1,158.77% |
| Sep 30, 2021 |
-2,961.67% |
